Boston Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$6.02M Sell
81,871
-7,187
-8% -$521K 0.31% 89
2019
Q2
$6.38M Sell
89,058
-97,256
-52% -$6.9M 0.34% 75
2019
Q1
$12.8M Buy
186,314
+88,761
+91% +$5.73M 0.65% 29
2018
Q4
$5.81M Sell
97,553
-13,929
-12% -$871K 0.34% 76
2018
Q3
$7.46M Buy
111,482
+3,673
+3% +$245K 0.32% 77
2018
Q2
$6.99M Buy
107,809
+41,448
+62% +$2.71M 0.17% 120
2018
Q1
$4.76M Sell
66,361
-78,545
-54% -$5.65M 0.12% 182
2017
Q4
$10.9M Buy
144,906
+518
+0.4% +$37.8K 0.24% 128
2017
Q3
$10.5M Sell
144,388
-98
-0.1% -$7.06K 0.24% 126
2017
Q2
$10.7M Buy
144,486
+10,888
+8% +$808K 0.25% 125
2017
Q1
$9.78M Sell
133,598
-17,062
-11% -$1.19M 0.23% 140
2016
Q4
$9.86M Buy
150,660
+2,137
+1% +$147K 0.24% 137
2016
Q3
$11M Sell
148,523
-33,316
-18% -$2.46M 0.27% 112
2016
Q2
$13.3M Sell
181,839
-443,903
-71% -$31.6M 0.33% 99
2016
Q1
$44.2M Buy
625,742
+33,036
+6% +$2.2M 1.09% 13
2015
Q4
$39.5M Buy
592,706
+327,058
+123% +$21.8M 0.92% 20
2015
Q3
$16.9M Buy
265,648
+9,946
+4% +$650K 0.63% 33
2015
Q2
$16.7M Sell
255,702
-108,212
-30% -$7.34M 0.7% 33
2015
Q1
$25.2M Buy
363,914
+29,004
+9% +$2M 1% 18
2014
Q4
$23.2M Sell
334,910
-48,959
-13% -$3.31M 0.98% 19
2014
Q3
$25M Buy
383,869
+3,560
+0.9% +$235K 1.06% 15
2014
Q2
$25.9M Buy
380,309
+155,826
+69% +$10.4M 1.11% 15
2014
Q1
$14.6M Buy
224,483
+155,062
+223% +$9.77M 0.65% 47
2013
Q4
$4.53M Buy
69,421
+7,233
+12% +$463K 0.22% 121
2013
Q3
$3.69M Buy
62,188
+46,160
+288% +$2.73M 0.2% 122
2013
Q2
$918K Buy
+16,028
New +$951K 0.04% 251

Other funds holding CL

Boston Advisors's CL Position: Q3 2019 in Review

Boston Advisors reduced its Colgate-Palmolive (CL) stake by 8.1% in Q3 2019, selling an estimated $521K and leaving 81,871 shares worth $6.02M. The position accounts for 0.31% of the portfolio, ranked #89.

Boston Advisors first reported a position in CL in Q2 2013 and has held it in 26 quarters since. The position peaked at $44.2M in Q1 2016. 1,446 funds tracked by Wall St. Rank hold CL as of Q3 2019.

  • Boston Advisors held 81,871 shares of Colgate-Palmolive worth $6.02M as of Q3 2019.
  • Boston Advisors sold 7,187 Colgate-Palmolive shares in Q3 2019, an estimated $521K.
  • Colgate-Palmolive made up 0.31% of Boston Advisors's portfolio in Q3 2019, its #89 holding.
  • Boston Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's Colgate-Palmolive position peaked at $44.2M in Q1 2016.
  • 1,446 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.